{"id":"W3119648922","doi":"10.1101/2021.01.07.21249390","title":"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; Université Laval; University of Alberta; University Health Network; University of Toronto; University of British Columbia; Université de Sherbrooke; St. Michael's Hospital","funders":"FP7 Health; NIHR Imperial Biomedical Research Centre; Health Research Council of New Zealand; Minderoo Foundation; Department of Health and Social Care; National Institute for Health and Care Research; Health Research Board; Medical Research Council; Breast Cancer Research Foundation; European Commission; Sanofi; Wellcome Trust; National Health and Medical Research Council","keywords":"Tocilizumab; Medicine; Interquartile range; Internal medicine; Intensive care unit; Odds ratio; Randomized controlled trial; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001750973,0.0005729283,0.001477004,0.0003783988,0.0001065841,0.00008632168,0.0005040409,0.0004927733,0.0006619871],"category_scores_gemma":[0.2944678,0.000456177,0.000323983,0.0004476146,0.0006842088,0.00008034195,0.002626055,0.002416477,0.00004752554],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001250067,"about_ca_system_score_gemma":0.004047395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004559766,"about_ca_topic_score_gemma":0.0001617087,"domain_scores_codex":[0.9939356,0.0004056801,0.001408182,0.001798205,0.001633445,0.0008188918],"domain_scores_gemma":[0.9878829,0.005181632,0.0003501925,0.002010741,0.003413654,0.00116084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002428257,0.0016099,0.9728551,0.005006855,0.0003023815,0.01275024,0.0007340975,0.00004203346,0.00008441737,0.00001308906,0.002696841,0.001476789],"study_design_scores_gemma":[0.003934555,0.001913332,0.9378398,0.003118454,0.0002235446,0.00003728584,0.0002948075,0.0001234627,0.0001755584,0.0001597156,0.05149895,0.0006805426],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9466003,0.0002755356,0.0011293,0.04825978,0.000781193,0.002027654,0.00008663021,0.0001723264,0.000667272],"genre_scores_gemma":[0.9756621,0.0005054589,0.003574408,0.01707298,0.0002745662,0.000472476,0.000788599,0.0001039237,0.00154548],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2927168,"threshold_uncertainty_score":0.999885,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04468168577270613,"score_gpt":0.406965089912327,"score_spread":0.3622834041396208,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}